HPV vaccination is beneficial for boys
Boys ages 11 through 21 should start getting vaccinated for human papillomavirus (HPV), according to a suggestion released last week by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention (CDC).
Vaccination provides many benefits for males, as well as females, who have been encouraged to receive them since the introduction of the Gardasil immunization in 2006. Since 2009, Cervarix, another vaccination, has been licensed for females, and Gardasil has been licensed for males, according to the CDC.
HPV, the most common sexually transmitted disease, affects 75 to 80 percent of males and females at some point in their lives, according to the New York Times. In some cases of infection, there are no symptoms. But in others, the infection leads to cancer, with 15,000 cases for women and 7,000 cases for men reported each year, according to the Times.
Head and neck cancers and anal cancers associated with oral and anal sex, respectively, may also be caused by HPV infections. Early vaccination is key, as it is less effective if given after sexual activity begins.
While the vaccination may be potentially expensive, costing more than $300 depending on insurance, protecting against cancer is priceless. A few hundred dollars spent on vaccinations pales in comparison to the high cost of cancer treatments, or even the pain and price associated with having genital warts removed.
While some parents may feel uncomfortable with vaccinating their sons, believing that the only boys who need it are homosexual, this is both a false and unfounded worry. Receiving the vaccine would help males' sexual partners regardless of gender, according to the Times, as oral sex has become more popular, and males are equally susceptible to getting cancer from the disease.
The vaccine also encourages male responsibility and egalitarian sex. Giving the vaccine to all sexes can pave the way for new technologies, such as male hormonal contraceptives, that will allow men to begin taking equal partnership in preventing pregnancy and STDs.
An injectable implant for men similar to Norplant, a long-term hormonal birth control placed under the skin of women's arms, is on its way to approval, Dr. Christina Wang, who is running clinical trials on the implant at Harbor-UCLA Medical Center, said to MSNBC. Several other male contraceptives, such as pills, patches and creams, are being researched and are also on their way to approval.
These male hormonal contraceptives are reversible, and much like the HPV vaccine for males, they allow men to protect the sexual health of themselves and others, finally making a historically female issue one for both sexes.
Jessica Schoenfeld is a sophomore majoring in sociology and women's and gender studies.
Get Top Stories Delivered Weekly
More usforacle News Articles
Recent usforacle News Articles
Discuss This Article
MOST POPULAR USFORACLE
GET TOP STORIES DELIVERED WEEKLY
FOLLOW OUR NEWSPAPER
LATEST USFORACLE NEWS
- Bedbugs found in USF business classrooms
- Harlan’s five-year plan shows budget is a work in progress
- Battle for employment
- Satellite camp debate missing the point
- Screen fires up Bulls for fourth-place finish in AAC
- Studies aim to help the hungry in Bay Area
- Bradley investigation closing, hiring process revised
FROM AROUND THE WEB
- A New Way to Deal With Dry Mouth
- Tamera Mowry-Housley Encourages Parents to Reclaim Family...
- Rolling Stones Exhibit Rocks Music Fans
- Enhance Your Summer Look With These Style Tips
- Hearing Loss Takes Center Stage With Free Test
- The Big Showdown Over Fingerprinting Uber and Lyft Drivers
- Encryption - Why It Matters to You
COLLEGE PRESS RELEASES
- FINALS SUCK: JOLLY RANCHER CANDY EMBRACES THE LONGEST, SUCKIEST WEEK OF COLLEGE
- Facebook & America East To Keynote College Sports Summit, June 1-3, GA
- Sodexo Reveals The 20ish Under 20ish Hunger Squad For 2016
- American Cancer Society and CVS Health Launch Bold Initiative to Help
- Course Hero Launches New Android App to Help Students Study Anywhere